利润表
CORBUS PHARMACEUTICALS HOLDINGS, INC.
CRBP
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
5.53 | 6.31 | - | 25.00 | 25.00 | 25.00 | 36.14 | 18.78 | 2.44 | 1.91 | 0.65 | - |
|
营业成本
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
毛利润
|
- | - | - | 25.00 | 25.00 | 25.00 | 36.14 | 18.78 | 2.44 | 1.91 | 0.65 | - |
|
营业费用
|
85.31 | 48.72 | 45.08 | 39.84 | 56.87 | 126.75 | 113.25 | 61.57 | 35.00 | 21.90 | 9.50 | 2.65 |
|
研发费用
|
70.10 | 32.22 | 31.17 | 16.14 | 36.45 | 98.27 | 89.60 | 48.61 | 26.04 | 15.44 | 5.89 | 1.26 |
|
销售、一般及行政费用
|
15.22 | 16.50 | 13.91 | 18.70 | 20.43 | 28.48 | 23.64 | 12.96 | 8.96 | 6.46 | 3.61 | 1.39 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-85.31 | -48.72 | -45.08 | -14.84 | -31.87 | -101.75 | -77.10 | -42.79 | -32.56 | -19.99 | -8.85 | -2.65 |
|
营业外收入
|
6.77 | 8.51 | 0.47 | -2.51 | 10.35 | 11.54 | 5.65 | 1.08 | 0.14 | -0.01 | 0.00 | 0.11 |
|
利息收入
|
- | - | - | - | - | - | 1.23 | - | - | - | 0.00 | 0.00 |
|
利息支出
|
0.00 | 1.80 | 3.81 | 3.10 | 2.71 | 1.13 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.02 |
|
其他营业外收入/支出
|
1.24 | 4.07 | 3.39 | -0.05 | 11.90 | - | - | - | - | - | - | - |
|
税前利润
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
所得税费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
少数股东损益
|
-78.54 | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
-78.54 | -40.21 | -44.60 | -42.35 | -45.64 | -111.27 | -71.45 | -55.67 | -32.42 | -20.00 | -8.85 | -2.54 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-85.08 | -48.13 | -44.44 | -14.07 | -30.87 | -100.62 | -76.37 | -42.29 | -32.31 | -19.90 | -8.85 | -2.65 |
|
基本每股收益
|
-5.90 | -3.68 | -10.31 | -10.15 | -0.37 | - | - | - | - | - | - | - |
|
稀释每股收益
|
-5.90 | -3.68 | -10.31 | -10.15 | - | - | - | - | - | - | - | - |
|
加权平均股数
|
13.32 | 10.92 | 4.33 | 4.17 | 122.99 | - | - | - | - | - | - | - |
|
稀释加权平均股数
|
13.32 | 10.92 | 4.33 | 4.17 | - | - | - | - | - | - | - | - |
|
综合收益
|
-78.63 | -40.17 | -44.48 | -42.41 | -45.70 | - | - | - | - | - | - | - |